Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Monopar Therapeutics Inc MNPR

Healthcare Biotechnology
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for cancer patients. The Company is building a drug candidate pipeline through in-house development as well as the licensing and acquisition of therapeutics in late preclinical and in clinical development stages. The Company has several compounds in development, which include MNPR-101-Zr... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MNPR)

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

GlobeNewswire April 18, 2024

Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings

GlobeNewswire April 16, 2024

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

GlobeNewswire April 10, 2024

Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments

GlobeNewswire March 28, 2024

Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program

GlobeNewswire March 5, 2024

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

GlobeNewswire February 27, 2024

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

GlobeNewswire February 22, 2024

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

GlobeNewswire February 20, 2024

Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments

GlobeNewswire November 9, 2023
View More News ››

Opinion & Analysis (NDAQ:MNPR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MNPR)

Monopar Announces Filing of Patent Protecting MNPR-101 Radio

Just In: $MNPR Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization FindingsWILMETTE, Ill., April 16, 2024...
whytestocks - April 16, 2024

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical

Breaking News: $MNPR Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical TrialWILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE...
whytestocks - February 27, 2024

What's Going On With Cancer-Focused Monopar Therapeutics Sto

JUST IN: $MNPR What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? | BenzingaMonopar Therapeutics Inc@(NASDAQ:MNPR...
whytestocks - February 22, 2024

Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | Benz

NEWS: $MNPR Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | BenzingaU.S. stocks traded higher midway through trading, with the...
whytestocks - February 22, 2024

MNPR ..... Let's go Baby !

over $1.00 now
Iseneschal - July 14, 2023

MNPR ..... No Position ; )

Chers !
Iseneschal - July 14, 2023
View more Bullboard ››

Benton Resources Inc.

Benton Resources Inc.

Benton Resources Inc. is a mineral exploration company listed on the TSX Venture Exchange under the symbol BEX. Benton has a ...
View More »